Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BORDET R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pu, Q; Wiel, E; Corseaux, D; Bordet, R; Azrin, MA; Ezekowitz, MD; Lund, N; Jude, B; Vallet, B
      Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endotheliumin Escherichia coli endotoxin-induced shock

      CRITICAL CARE MEDICINE
    2. Bordet, R; Gautier, S; Le Louet, H; Dupuis, B; Caron, J
      Analysis of the direct cost of adverse drug reactions in hospitalised patients

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    3. Wiel, E; Pu, Q; Corseaux, D; Robin, E; Bordet, R; Lund, N; Jude, B; Vallet, B
      Effect of L-arginine on endothelial injury and hemostasis in rabbit endotoxin shock

      JOURNAL OF APPLIED PHYSIOLOGY
    4. Bordet, R; Ridray, S; Schwartz, JC; Sokoloff, P
      Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    5. Bordet, R; Pu, Q; Puisieux, F; Deplanque, D; Jaboureck, O; Leys, D; Vallet, B; Dupuis, B
      Susceptibility to provoked cerebral infarction is not increased in a rat model of pharmacologically-induced hypertension despite endothelial dysfunction

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    6. Bordet, R; Deplanque, D; Maboudou, P; Puisieux, F; Pu, Q; Robin, E; Martin, A; Bastide, M; Leys, D; Lhermitte, M; Dupuis, B
      Increase in endogenous brain superoxide dismutase as a potential mechanismof lipopolysaccharide-induced brain ischemic tolerance

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    7. Leclerc, J; Pu, Q; Corseaux, D; Haddad, E; Decoene, C; Bordet, R; Six, I; Jude, B; Vallet, B
      A single endotoxin injection in the rabbit causes prolonged blood vessel dysfunction and a procoagulant state

      CRITICAL CARE MEDICINE
    8. Deplanque, D; Bordet, R
      Pharmacological preconditioning with lipopolysaccharide in the brain

      STROKE
    9. Puisieux, F; Deplanque, D; Pu, Q; Souil, E; Bastide, M; Bordet, R
      Differential role of nitric oxide pathway and heat shock protein in preconditioning and lipopolysaccharide-induced brain ischemic tolerance

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Corseaux, D; Meurice, T; Six, I; Rugeri, L; Ezekowitz, MD; Rouvier, P; Bordet, R; Bauters, C; Jude, B
      Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall

      CIRCULATION
    11. Deplanque, D; Bastide, M; Bordet, R
      Ischaemic preconditioning of the endothelium and smooth muscle of cerebralarteries

      TRENDS IN PHARMACOLOGICAL SCIENCES
    12. Caron, J; Gautier, S; Couderc, E; Bordet, R
      Significance of pharmacovigilance: Proarrhythmic effects of drugs in current use

      ARCHIVES DE PEDIATRIE
    13. Catteau, J; Cyran, C; Bordet, R; Thomas, CE; Dupuis, BA
      What are the reciprocal influences of randomized clinical trials and the patient-psychiatrist relationship?

      EUROPEAN PSYCHIATRY
    14. Bastide, M; Bordet, R; Pu, Q; Robin, E; Puisieux, F; Dupuis, B
      Relationship between inward rectifier potassium current impairment and brain injury after cerebral ischemia/reperfusion

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    15. Pu, Q; Bordet, R; Robin, E; Puisieux, F; Vallet, B; Dupuis, B
      Low dose of lipopolysaccharide induces a delayed enhanced nitric oxide-mediated relaxation in rat aorta

      EUROPEAN JOURNAL OF PHARMACOLOGY
    16. Six, I; Van Belle, E; Bordet, R; Corseaux, D; Callebert, J; Dupuis, B; Bauters, C; Bertrand, ME
      L-Arginine and L-NAME have no effects on the reendothelialization process after arterial balloon injury

      CARDIOVASCULAR RESEARCH
    17. BEREGI JP; LAHOCHE A; WILLOTEAUX S; MCFADDEN E; BORDET R; GAUTIER C; ETCHRIVI T
      RENAL-ARTERY VASOMOTION - IN-VIVO ASSESSMENT IN THE PIG WITH INTRAVASCULAR DOPPLER

      Fundamental and clinical pharmacology
    18. ADAMANTIDIS MM; DUMOTIER BM; CARON JF; BORDET R
      SPARFLOXACIN BUT NOT LEVOFLOXACIN OR OFLOXACIN PROLONGS CARDIAC REPOLARIZATION IN RABBIT PURKINJE-FIBERS

      Fundamental and clinical pharmacology
    19. SCHWARTZ JC; DIAZ J; BORDET R; GRIFFON N; PERACHON S; PILON C; RIDRAY S; SOKOLOFF P
      FUNCTIONAL IMPLICATIONS OF MULTIPLE DOPAMINE-RECEPTOR SUBTYPES - THE D-1 D-3 RECEPTOR COEXISTENCE/

      Brain research reviews
    20. SCHWARTZ JC; DIAZ J; BORDET R; GRIFFON N; PERACHON S; PILON C; RIDRAY S; SOKOLOFF P
      THE D-3 RECEPTOR AND ITS LIGANDS

      Naunyn-Schmiedeberg's archives of pharmacology
    21. SIX I; VANBELLE E; VALLET B; CORSEAX D; BORDET R; LETOURNEAU T; DUPUIS B; BAUTERS C; BARTRAND ME
      FGF - A PROTECTIVE FACTOR FOR ENDOTHELIAL-CELLS IN THE EARLY STAGES OF ATHEROSCLEROSIS

      Circulation
    22. BORDET R; THOMAS P; DUPUIS B
      EFFECT OF PINDOLOL ON ONSET OF ACTION OF PAROXETINE IN THE TREATMENT OF MAJOR DEPRESSION - INTERMEDIATE ANALYSIS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      The American journal of psychiatry
    23. BORDET R; VERWAERDE P; TRAN MA; MARQUES MA; MONTASTRUC JL; SENARD JM
      EFFECTS OF OCTREOTIDE ON EXPERIMENTAL NEUROGENIC ORTHOSTATIC HYPOTENSION IN ANESTHETIZED DOGS

      Fundamental and clinical pharmacology
    24. BORDET R; THOMAS P
      SELECTIVE SEROTONIN REUPTAKE INHIBITORS PLUS PINDOLOL

      Lancet
    25. BEREGI J; GAUTIER C; MACFADDEN E; LIBERSA C; BORDET R; MOUNIERVEHIER C
      VASOMOTOR RESPONSE OF NON-STENOSED RENAL-ARTERIES IN PATIENTS WITH SYSTEMIC HYPERTENSION - AN INTRAVASCULAR DOPPLER STUDY

      Radiology
    26. BORDET R; BELABBAS A; LHERMITTE M; TRICOT O; ROUSSEL P; LIBERSA C
      IS THERE ANY DIFFERENCE BETWEEN DAYTIME AND NIGHTTIME DEBRISOQUINE METABOLISM

      European Journal of Clinical Pharmacology
    27. BORDET R; RIDRAY S; CARBON S; DIAZ J; SOKOLOFF P; SCHWARTZ JC
      INDUCTION OF DOPAMINE D-3 RECEPTOR EXPRESSION AS A MECHANISM OF BEHAVIORAL SENSITIZATION TO LEVODOPA

      Proceedings of the National Academy of Sciences of the United Statesof America
    28. REMY J; DESCHILDRE F; ARTAUD D; REMYJARDIN M; COPIN MC; BORDET R; GOSSELIN B
      BRONCHIAL ARTERIES IN THE PIG BEFORE AND AFTER PERMANENT PULMONARY-ARTERY OCCLUSION

      Investigative radiology
    29. SIX I; VANBELLE E; BORDET R; CORSEAUX D; MEURICE T; DUPUIS B; BAUTERS C; BERTRAND ME
      NITRIC-OXIDE IS NOT INVOLVED IN ENDOTHELIAL REGROWTH IN-VIVO - RESULTS IN A RABBIT BALLOON INJURY MODEL

      Circulation
    30. BORDET R; BENHADJALI J; DESTEE A; HURTEVENT JF; BOURRIEZ JL; GUIEU JD
      SYMPATHETIC SKIN-RESPONSE AND R-R INTERVAL VARIABILITY IN MULTIPLE SYSTEM ATROPHY AND IDIOPATHIC PARKINSONS-DISEASE

      Movement disorders
    31. BORDET R; BROLY F; DESTEE A; LIBERSA C; LAFITTE JJ
      LACK OF RELATION BETWEEN GENETIC-POLYMORPHISM OF CYTOCHROME P-450IID6AND SPORADIC IDIOPATHIC PARKINSONS-DISEASE

      Clinical neuropharmacology
    32. VERWAERDE P; BORDET R; PORTOLAN G; TRAN MA; MARQUES MA; MONTASTRUC JL; SENARD JM
      LACK OF EFFECT OF OCTREOTIDE ON EXPERIMEN TAL ORTHOSTATIC HYPOTENSIONIN SINOAORTIC DENERVATED DOGS

      Archives des maladies du coeur et des vaisseaux
    33. VERMERSCH P; BORDET R; LEDOZE F; RUCHOUX MM; CHAPON F; THOMAS P; DESTEE A; LECHEVALLIER B; DELACOURTE A
      DEMONSTRATION OF A SPECIFIC PROFILE OF PA THOLOGICAL TAU-PROTEINS IN FRONTOTEMPORAL DEMENTIA CASES

      Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie
    34. BORDET R; BENHADJALI J; DESTEE A; BELABBAS A; LIBERSA C
      OCTREOTIDE EFFECTS ON ORTHOSTATIC HYPOTENSION IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY - A CONTROLLED-STUDY OF ACUTE ADMINISTRATION

      Clinical neuropharmacology
    35. LIBERSA C; BORDET R; CARON J; GUEDONMOREAU L
      VASCULAR IMPACT OF DIHYDROPYRIDINES CALCI UM-ANTAGONISTS

      Therapie
    36. BORDET R; BROLY F; DESTEE A; LIBERSA C
      GENETIC-POLYMORPHISM OF CYTOCHROME-P450 2D6 IN IDIOPATHIC PARKINSON DISEASE AND DIFFUSE LEWY BODY DISEASE

      Clinical neuropharmacology
    37. BORDET R; BENHADJALI J; LIBERSA C; DESTEE A
      OCTREOTIDE IN THE MANAGEMENT OF ORTHOSTATIC HYPOTENSION IN MULTIPLE SYSTEM ATROPHY - PILOT TRIAL OF CHRONIC ADMINISTRATION

      Clinical neuropharmacology
    38. LIBERSA C; CARON J; GUEDONMOREAU L; TRICOT O; BORDET R
      METHODS OF ANTIARRHYTHMIC DRUGS EVALUATIO N IN HUMANS

      Therapie
    39. BORDET R; CARON J; DESTEE A; DUPUIS B
      PROGRESSIVE MUSCULAR-DYSTROPHY AND MEDICI NAL RISK

      Therapie
    40. BORDET R; BENHADJALI J; LIBERSA C; DESTEE A
      OCTREOTIDE EFFECTS ON ORTHOSTATIC HYPOTENSION IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY - A CONTROLLED-STUDY OF ACUTE ADMINISTRATION

      Neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 04:58:50